The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors
about
Platelet Interaction with Innate Immune CellsLysophosphatidic acid (LPA) signaling in human and ruminant reproductive tractModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsGeneration and biological activities of oxidized phospholipidsStabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaquesMechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice.Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry.Lysophosphatidic acid in atherosclerotic diseasesGPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaquesLysophospholipid mediators in the vasculatureLysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.Novel uses for anti-platelet agents as anti-inflammatory drugs.Identification of hemostatic genes expressed in human and rat leg muscles and a novel gene (LPP1/PAP2A) suppressed during prolonged physical inactivity (sitting).Roles of lysophosphatidic acid in cardiovascular physiology and diseaseTherapeutic potential of autotaxin/lysophospholipase d inhibitors.Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosisLysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients.Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.Roles of LPA in ovarian cancer development and progression.Lysophosphatidic acid effects on atherosclerosis and thrombosis.Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.Lysophospholipid signaling: beyond the EDGs.Cerebellar astrocytes co-express several ADP receptors. Presence of functional P2Y(13)-like receptors.Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids.Mechanism of platelet activation induced by endocannabinoids in blood and plasma.Effect of intravenous lidocaine on the transcerebral inflammatory response during cardiac surgery: a randomized-controlled trial.Adhesive interaction between peripheral blood mononuclear cells and activated platelets in the presence of anti-human leukocyte antigen Class I alloantibody causes production of IL-1β and IL-8.Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge.
P2860
Q26745910-1B243049-BC8A-455C-B506-E85C31264A6DQ26829938-5E6DDC13-5D90-461D-98CE-094B641CE2C8Q28074264-226C1075-F3AE-4000-804C-1296C5C87697Q28389691-98E04949-EF48-4DAF-A1CA-C68D0E523743Q28752603-7CC32313-1DE3-4951-AA7D-8CB05D1DCE69Q30410474-6716745F-FC60-4903-BF4A-F0F7E51D6F90Q33636488-594141FF-B4F7-4F8C-96A1-AF68B145B543Q33641499-BA77D8B6-B34F-4FBB-B9D0-410F8E731606Q33881728-D45C57E1-DA2A-4372-A501-A278C61A2763Q34273486-4A605B66-1825-469A-8277-1696D8264A47Q34682812-4DCA71A1-14FB-4551-BBAE-5B5318873990Q35533485-53784D6F-ACF0-4A97-8C29-B25DABAF4104Q35907288-8C7DB01E-0587-4CC0-8DF0-FA3B25A85A57Q36171374-7CB96E61-F21A-4379-B568-2A5F8E235BD2Q36517591-5CBF2C9C-A456-49F0-AE93-9C842A90A172Q36948520-199FCF75-C4DB-4CF1-90A3-424B175A7BAAQ37049044-8B1B7CBD-D882-4FC2-A1B2-429DE3948E05Q37119757-B3CB12F9-CA31-43F6-BFBE-5513222B7CACQ37375487-D0818BC3-3DB4-49A0-957E-5E0FD725BD05Q37510154-838761C2-46C3-46E8-A2AC-60F64A929A96Q37620329-8893EC8A-8381-4BB6-A024-87A83BE9D071Q37650618-99884373-2473-4F6C-B946-34D2DADC2D44Q39608397-CD3CA7E6-CFA1-49DB-A9FA-BDE0B1DC65CEQ39987593-407B64DF-6778-47D0-A189-68D042567005Q40068942-063A2FDC-3D11-4D8F-9090-BE9D8740822BQ40722550-BDCEAFD8-196D-49D1-B289-D8E3F368F18CQ42135026-782662FD-2D88-45A6-B971-B354D3340F91Q44500279-9BA3DC3C-ED3C-45A6-9833-C90E2B7644B9Q47404107-78F0E635-9A32-4515-8EBA-C3BE7491BC9CQ50526083-131ED3CA-B038-4E8F-9C63-1E4FA595992AQ53566196-82692AB4-DA15-406F-B4BF-7D4BF5EAC306
P2860
The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@ast
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@en
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@nl
type
label
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@ast
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@en
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@nl
prefLabel
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@ast
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@en
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@nl
P2093
P1433
P1476
The plaque lipid lysophosphati ...... nt of P2Y1 and P2Y12 receptors
@en
P2093
Catherine Ravanat
Christian Gachet
Gabor Tigyi
Nadine Haserück
Philippe Ohlmann
Wolfgang Erl
Wolfgang Siess
P304
P356
10.1182/BLOOD-2003-04-1127
P407
P577
2003-11-26T00:00:00Z